Breaking News

Johnson & Johnson to Invest Over $1B in Cell Therapy Manufacturing Facility in PA

Will support more than 500 skilled biomanufacturing jobs when fully operational and more than 4,000 construction jobs during site development.

Author Image

By: Charlie Sternberg

Associate Editor

Johnson & Johnson will invest more than $1 billion in a next generation cell therapy manufacturing facility in Montgomery County, Pennsylvania, further expanding its U.S. manufacturing capacity as it advances its portfolio and pipeline of transformational medicines. “For 140 years, Johnson & Johnson has been a leading innovator in American healthcare, and we are honored to continue advancing that legacy in Pennsylvania,” said Joaquin Duato, Chairman and CEO of Johnson & Johnson. “...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters